The Circulating Tumor Cell Core Facility uses immunomagnetic technology developed by Veridex, LLC (Raritan, NJ) to isolate rare tumor cells from whole blood. Isolated tumor cells can then be counted or used for downstream analysis such as molecular studies or flow cytometry.
Fluorescence based cellular analysis of cells captured by the CellTracks AutoPrep system. Use for the quantitative analysis of circulating tumor cells.
Automated preparation system for the standardized preparation of blood samples to detect circulating tumor cells using magnetic cell capture and immunostaining.
Analysis of blood samples (7.5mls collected in Veridex CellSave tubes) for the presence of circulating tumor cells
Processed samples of circulating tumor cells are returned to investigators for downstream analysis (i.e. profiling).